Trends in Complications and Outcomes in Patients Aged 65 Years and Younger Undergoing Total Knee Arthroplasty: Data From the American Joint Replacement Registry

医学 生存曲线 共病 查尔森共病指数 关节置换术 外科 单变量分析 回顾性队列研究 人口
作者
Akash Shah,David Alexander Cieremans,James Slover,Ran Schwarzkopf,Morteza Meftah
出处
期刊:Journal of the American Academy of Orthopaedic Surgeons [Wolters Kluwer]
卷期号:6 (6)
标识
DOI:10.5435/jaaosglobal-d-22-00116
摘要

The purpose of this study was to identify common complications and the rates of readmission and revision in total knee arthroplasty (TKA) patients younger than 65 years.Using the American Joint Replacement Registry, we conducted a retrospective review of all TKAs done in patients aged 18 to 65 years from 2012 to 2020. Demographic factors such as age, sex, Charlson Comorbidity Index (CCI), and preoperative Veterans RAND 12-Item Health Survey Physical Component Summary (VR-12 PCS) scores were collected. We excluded patients older than 65 years and revision, oncologic, and nonelective cases. Primary outcomes included cumulative revision rate, 90-day readmission rate, and reason for revision. Univariate analysis and the Kaplan-Meier method were used.Six thousand one hundred seventy-nine patients were included. The average age was 58.8 years (SD 5.5 years), 61% were female, 82% were White, and 88% had a CCI of 0 (1 = 8% and ≥2 = 4%). The mean follow-up was 42.51 months. Seventy-four patients (1.2%) underwent revision. Sixty-nine patients (1.1%) were readmitted within 90 days. No factors assessed increased revision rates. Revision-free survivorship was 98.7% (95% CI 98.4 to 99.0) and 98.6% (95% CI 98.2 to 99.0) at 5 and 8 years, respectively. Infection (15%), aseptic loosening (14%), and instability (12%) were the most common indications for revision.TKA done in young and presumed active patients has excellent survivorship. Long-term follow-up is needed to assess survival trends in this growing population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
创不可贴完成签到,获得积分10
2秒前
zhhh发布了新的文献求助10
3秒前
灯火阑珊曦完成签到,获得积分10
3秒前
3秒前
天才包完成签到,获得积分10
4秒前
淡然以柳完成签到 ,获得积分10
4秒前
lxaiczn应助xxx采纳,获得10
5秒前
xiaobao完成签到,获得积分10
6秒前
6秒前
叮咚雨发布了新的文献求助10
6秒前
想要毕业完成签到,获得积分10
7秒前
mumuaidafu完成签到 ,获得积分10
7秒前
8秒前
时庆钰完成签到,获得积分10
8秒前
catherine完成签到,获得积分10
8秒前
9秒前
9秒前
文静金针菇完成签到 ,获得积分10
9秒前
仰山雪完成签到 ,获得积分10
10秒前
11秒前
平淡一兰完成签到,获得积分10
11秒前
传奇3应助huoshan采纳,获得10
12秒前
12秒前
13秒前
wyk完成签到,获得积分10
13秒前
香蕉觅云应助天地一沙鸥采纳,获得10
14秒前
14秒前
14秒前
剑九黄完成签到,获得积分10
15秒前
Soda8513完成签到,获得积分10
15秒前
健康的行天完成签到 ,获得积分10
17秒前
华仔应助卖萌的秋田采纳,获得10
17秒前
penguo应助欧皇采纳,获得10
17秒前
田様应助xiamu.采纳,获得30
17秒前
冷静烨霖发布了新的文献求助10
18秒前
科研通AI6.3应助屈春洋采纳,获得10
19秒前
20秒前
sun发布了新的文献求助30
20秒前
山野的雾完成签到 ,获得积分10
20秒前
xxx完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6022078
求助须知:如何正确求助?哪些是违规求助? 7639624
关于积分的说明 16168103
捐赠科研通 5170100
什么是DOI,文献DOI怎么找? 2766707
邀请新用户注册赠送积分活动 1749852
关于科研通互助平台的介绍 1636783